Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
US Stem Cell Inc (USRM)
OTHER OTC:USRM
Holding USRM?
Track your performance easily
USRM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume113.66K
Average Volume (3M)N/A
Market Cap
$64.15K
Enterprise Value$9.01M
Total Cash (Recent Filing)$5.13K
Total Debt (Recent Filing)$8.95M
Price to Earnings (P/E)―
Beta2.02
Next Earnings
Aug 07, 2019EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding641,507,317
10 Day Avg. Volume27,894
30 Day Avg. VolumeN/A
Standard Deviation12.90
R-Squared0.02
Alpha2.06
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.08
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue135.35
Enterprise Value/Gross Profit154.52
Enterprise Value/Ebitda-4.98
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
US Stem Cell News
Ownership Overview
12.50%
Insiders
0.00%
Mutual Funds
0.00% Other Institutional Investors
87.50% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
USRM FAQ
What was US Stem Cell Inc’s price range in the past 12 months?
Currently, no data Available
What is US Stem Cell Inc’s market cap?
Currently, no data Available
When is US Stem Cell Inc’s upcoming earnings report date?
US Stem Cell Inc’s upcoming earnings report date is Aug 07, 2019 which is 1922 days ago.
How were US Stem Cell Inc’s earnings last quarter?
US Stem Cell Inc released its earnings results on May 07, 2019. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is US Stem Cell Inc overvalued?
According to Wall Street analysts US Stem Cell Inc’s price is currently Overvalued.
Does US Stem Cell Inc pay dividends?
US Stem Cell Inc does not currently pay dividends.
What is US Stem Cell Inc’s EPS estimate?
US Stem Cell Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does US Stem Cell Inc have?
US Stem Cell Inc has 641,507,300 shares outstanding.
What happened to US Stem Cell Inc’s price movement after its last earnings report?
US Stem Cell Inc reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of US Stem Cell Inc?
Currently, no hedge funds are holding shares in USRM
---
Company Description
US Stem Cell Inc
U.S. Stem Cell, Inc. is a biotechnology company, which focuses on the discovery, development, and subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its product MyoCell, deals with the clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company was founded by Howard J. Leonhardt and Robert D. Lashinski on August 12, 1999 and is headquartered in Sunrise, FL.
---
---